| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- bài báo khoa học (vi)
- наукова стаття, опублікована в січні 1999 (uk)
- articolo scientifico (pubblicato il 1999) (it)
- 1999 թվականին հրատարակված գիտական հոդված (hy)
- im Januar 1999 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xineru de 1999 (ast)
- artikull shkencor i botuar më 01 janar 1999 (sq)
- scientific article published on 01 January 1999 (en)
|
| publication date
| |
| publication date
| |
| exact match
| |
| exact match
| |
| author name string
| |
| author name string
| - D Jones
- E Weidekamm
- W Steward
- J Cassidy
- B Reigner
- D Cameron
- L Banken
- K O'Byrne
- B Roos
- D Jodrell
- T Goggin
- E Bush
|
| rdfs:label
| - Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients (en)
- Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients (nl)
- Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients (sq)
|
| skos:prefLabel
| - Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients (en)
- Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients (nl)
- Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients (sq)
|
| name
| - Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients (en)
- Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients (nl)
- Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients (sq)
|
| author
| |
| author
| |
| title
| |
| title
| - Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| |
| Dimensions Publication ID
| |
| Dimensions Publication ID
| |
| is about
of | |
| is cites work
of | |
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)